Long-term saliva sampling for Barrett's esophagus
Official title: Repeated Sampling of the Oral Microbiome to Improve Detection of Barrett's Esophagus
Run by Columbia University · NCT05133102 · Data updated 2026-11-12
This study is testing if regular saliva samples can help identify a specific oral bacteria pattern in people with Barrett's esophagus to see if it can be used as a simple way to diagnose this condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 275 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 2 sites (Ann Arbor, Michigan and 1 other locations) |
| Status | Recruiting |
| Started | March 19, 2021 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT05133102 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are scheduled for or have had an upper endoscopy within the last three years and have been diagnosed with Barrett's esophagus.
✕Probably not a fit
Patients with a history of head and neck cancer, esophageal squamous cell or gastric cancer, or those who have undergone certain types of esophageal or gastric surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to evaluate the effectiveness of repeated saliva sampling to identify a microbiome signature associated with Barrett's esophagus (BE). Participants will be selected from patients who have undergone an endoscopy in the past three years. The study will assess whether the oral microbiome can serve as a reliable, non-invasive diagnostic tool for BE, which is a precursor to esophageal cancer. By analyzing saliva samples over time, the researchers hope to determine the stability and reproducibility of the microbiome signature in individuals diagnosed with BE.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive method for diagnosing and monitoring Barrett's esophagus, potentially reducing the need for invasive endoscopic procedures.
How similar studies have gone: While the approach of using saliva microbiome analysis is relatively novel, previous studies have indicated distinct microbiome profiles in patients with Barrett's esophagus, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Scheduled for an upper endoscopy or had upper endoscopy within past three years * Eighteen years of age or older * Capable of producing a saliva sample * Able to give informed consent * For BE patients only: Endoscopic evidence of Barrett's esophagus (at least 1 cm maximal BE length; i.e. Prague classification: any C, M≥1), and intestinal metaplasia present on esophageal biopsies Exclusion Criteria: * History of head and neck cancer or esophageal squamous cell or gastric cancer * History of esophageal or gastric surgery * Scheduled to undergo colonoscopy on the day of initial saliva collection * Scheduled only for Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopy ultrasound (EUS) without accompanying standard upper endoscopy on the day of initial saliva collection * For BE patients only: History of prior endoscopic therapy for BE except a history of prior Endoscopic mucosal resection (EMR) of focal lesions without subsequent ablative therapy is permitted
Where it's running
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting -
Columbia University Irving Medical Center
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Julian Abrams, MD — Columbia University
- Study coordinator: Julian Abrams, MD
- Email: ja660@cumc.columbia.edu
- Phone: 212-305-1909
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictors of symptom improvement after laparoscopic fundoplication
This study tests what preoperative factors help predict which GERD patients will feel better after laparoscopic fundoplication.
-
Potassium-Competitive Acid Blockers in Barrett’s Esophagus on PPI Therapy
This study tests whether vonoprazan, a potassium-competitive acid blocker, can better reduce acid reflux in adults with nondysplastic Barrett’s esophagus who are already taking a daily PPI.
-
How radiofrequency ablation affects esophagus stretchiness and mucosal impedance
This study will test whether radiofrequency ablation changes how stretchy the esophagus is and the mucosal impedance in adults treated for dysplastic Barrett's esophagus.
-
Detecting Barrett's Esophagus with a Non-Endoscopic Device
This study is testing a new capsule device that collects cells from the esophagus to see if it can effectively detect Barrett's Esophagus in people at high risk, without needing an endoscopy.
-
Stopping routine endoscopic surveillance for low-risk Barrett's esophagus (BLISS Project)
This project will try stopping routine endoscopies in people with low-risk, non-dysplastic Barrett's esophagus to see if it remains safe.
-
Non-endoscopic test to find Barrett's esophagus in veterans without chronic reflux.
This project will test whether a simple, non-endoscopic swab-like test can find Barrett's esophagus in veterans over 40 who have risk factors for esophageal cancer but no chronic heartburn.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.